TRIDENT LIFELINE
Back to Cashflow Statement
|
TRIDENT LIFELINE Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-14 Cr | ₹-20 Cr | ₹-9.69 Cr | ₹-0.45 Cr |
What is the latest Cash Flow from Investing Activities ratio of TRIDENT LIFELINE ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-14 Cr |
| Mar2024 | ₹-20 Cr |
| Mar2023 | ₹-9.69 Cr |
| Mar2022 | ₹-0.45 Cr |
How is Cash Flow from Investing Activities of TRIDENT LIFELINE Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-14 Cr | Negative | |
| Mar2024 | ₹-20 Cr | Negative | |
| Mar2023 | ₹-9.69 Cr | Negative | |
| Mar2022 | ₹-0.45 Cr | - | |
Compare Cash Flow from Investing Activities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹489.2 Cr | 10.6% | 49.6% | 27.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 10.6% |
49.6% |
27.6% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses